• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短聚乙二醇引发的聚 L-乳酸两嵌段共聚物调控药物释放。

Modulating Drug Release from Short Poly(ethylene glycol) Block Initiated Poly(L-lactide) Di-block Copolymers.

机构信息

Department of Materials Science and Metallurgy, University of Cambridge, Cambridge, UK.

Ashland Specialties Ireland Ltd., National Science Park, Building V, Dublin Road, Petitswood, Mullingar, Co. Westmeath, Ireland.

出版信息

Pharm Res. 2023 Jul;40(7):1697-1707. doi: 10.1007/s11095-022-03228-8. Epub 2022 Apr 26.

DOI:10.1007/s11095-022-03228-8
PMID:35474159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10421795/
Abstract

This paper investigates drug release from a novel series of mPEG-functionalised PLLA polymers whose individual components (PEG and PLLA) have regulatory FDA approval. Two processing methods were explored to understand their effect on the morphology and drug release profiles of the polymers, with and without mPEG functionalisation. In the first method the polymer and Propranolol.HCl drug powders were mixed together before injection moulding. In the second method, supercritical CO was used to mix the polymer and drug before injection moulding. When non-functionalised PLLA was processed through injection moulding alone, there were no signs of polymer-drug interaction, and the drug was confined to crystals on the surface. This resulted in up to 85 wt% burst release of propranolol.HCl after one day of incubation. By contrast, injection moulding of mPEG-functionalised polymers resulted in the partial dissolution of drug in the polymer matrix and a smaller burst (50 wt% drug) followed by sustained release. This initial burst release was completely eliminated from the profile of mPEG-functionalised polymers processed via supercritical CO. The addition of mPEG facilitated the distribution of the drug into the bulk matrix of the polymer. Paired with supercritical CO processing, the drug release profile showed a slow, sustained release throughout the 4 months of the study.

摘要

本文研究了一系列新型 mPEG 功能化 PLLA 聚合物的药物释放情况,这些聚合物的单体成分(PEG 和 PLLA)均获得了美国 FDA 的监管批准。本文探索了两种加工方法,以了解它们对聚合物形态和药物释放曲线的影响,这些聚合物有无 mPEG 功能化。在第一种方法中,聚合物和盐酸普萘洛尔药物粉末在注塑前混合在一起。在第二种方法中,超临界 CO 用于在注塑前混合聚合物和药物。当非功能化 PLLA 单独通过注塑加工时,没有聚合物-药物相互作用的迹象,药物被限制在表面的晶体上。这导致在孵育一天后,盐酸普萘洛尔的突释高达 85wt%。相比之下,mPEG 功能化聚合物的注塑加工导致药物部分溶解在聚合物基质中,突释(50wt%药物)较小,随后是持续释放。通过超临界 CO 加工的 mPEG 功能化聚合物的药物释放曲线完全消除了这种初始突释。mPEG 的添加促进了药物在聚合物基质中的分布。与超临界 CO 加工相结合,药物释放曲线在 4 个月的研究期间显示出缓慢、持续的释放。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/f4bc5c46c7e1/11095_2022_3228_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/983d29304c71/11095_2022_3228_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/05c553cb27af/11095_2022_3228_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/5bfc22cfbd35/11095_2022_3228_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/bc8ae4f8b720/11095_2022_3228_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/c8e5f881b135/11095_2022_3228_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/bd50bd9a5fe0/11095_2022_3228_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/f4bc5c46c7e1/11095_2022_3228_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/983d29304c71/11095_2022_3228_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/05c553cb27af/11095_2022_3228_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/5bfc22cfbd35/11095_2022_3228_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/bc8ae4f8b720/11095_2022_3228_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/c8e5f881b135/11095_2022_3228_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/bd50bd9a5fe0/11095_2022_3228_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caa4/10421795/f4bc5c46c7e1/11095_2022_3228_Fig7_HTML.jpg

相似文献

1
Modulating Drug Release from Short Poly(ethylene glycol) Block Initiated Poly(L-lactide) Di-block Copolymers.短聚乙二醇引发的聚 L-乳酸两嵌段共聚物调控药物释放。
Pharm Res. 2023 Jul;40(7):1697-1707. doi: 10.1007/s11095-022-03228-8. Epub 2022 Apr 26.
2
Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.基于Boltorn H40、聚(L-丙交酯)和聚(乙二醇)的叶酸共轭两亲性超支化嵌段共聚物用于肿瘤靶向给药
Biomaterials. 2009 Jun;30(16):3009-19. doi: 10.1016/j.biomaterials.2009.02.011. Epub 2009 Feb 27.
3
Poly(L-lactide)-b-poly(ethylene oxide) copolymers with different arms: hydrophilicity, biodegradable nanoparticles, in vitro degradation, and drug-release behavior.具有不同臂的聚(L-丙交酯)-b-聚(环氧乙烷)共聚物:亲水性、可生物降解纳米颗粒、体外降解及药物释放行为
J Biomed Mater Res A. 2009 Mar 15;88(4):990-9. doi: 10.1002/jbm.a.31945.
4
Effect of mPEG-PLGA on Drug Crystallinity and Release of Long-Acting Injection Microspheres: In Vitro and In Vivo Perspectives.mPEG-PLGA 对长效注射微球药物结晶度和释放的影响:体外和体内研究。
Pharm Res. 2024 Jun;41(6):1271-1284. doi: 10.1007/s11095-024-03717-y. Epub 2024 Jun 5.
5
Sunitinib microspheres based on [PDLLA-PEG-PDLLA]-b-PLLA multi-block copolymers for ocular drug delivery.基于[聚(D,L-乳酸)-聚乙二醇-聚(D,L-乳酸)]-b-聚(L-乳酸)多嵌段共聚物的舒尼替尼微球用于眼部药物递送。
Eur J Pharm Biopharm. 2015 Sep;95(Pt B):368-77. doi: 10.1016/j.ejpb.2015.02.011. Epub 2015 Feb 19.
6
Tailoring the properties of mPEG-PLLA nanoparticles for better encapsulation and tuned release of the hydrophilic anticancer drug.定制甲氧基聚乙二醇-聚乳酸纳米粒的性质以实现对亲水性抗癌药物更好的包封和调控释放。
Drug Deliv Transl Res. 2017 Jun;7(3):416-427. doi: 10.1007/s13346-017-0372-9.
7
Protein release from water-swellable poly(D,L-lactide-PEG)-b-poly(ϵ-caprolactone) implants.水凝胶聚(D,L-丙交酯-PEG)-b-聚(ε-己内酯)植入物中蛋白质的释放。
Int J Pharm. 2015 Mar 1;480(1-2):73-83. doi: 10.1016/j.ijpharm.2015.01.007. Epub 2015 Jan 6.
8
Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers.叶酸偶联两亲性星形嵌段共聚物作为靶向纳米载体。
J Biomed Mater Res A. 2011 Jun 15;97(4):498-508. doi: 10.1002/jbm.a.33071. Epub 2011 Apr 20.
9
Self-assembling methoxypoly(ethylene glycol)-b-poly(carbonate-co-L-lactide) block copolymers for drug delivery.用于药物递送的自组装甲氧基聚(乙二醇)-b-聚(碳酸酯-co-L-丙交酯)嵌段共聚物。
Biomaterials. 2010 Mar;31(8):2358-70. doi: 10.1016/j.biomaterials.2009.11.081.
10
Synthesis, characterization and evaluation of tinidazole-loaded mPEG-PDLLA (10/90) in situ gel forming system for periodontitis treatment.载替硝唑的 mPEG-PDLLA(10/90)原位凝胶形成体系的合成、表征及在牙周炎治疗中的评价。
Drug Deliv. 2016 Oct;23(8):2726-2735. doi: 10.3109/10717544.2015.1061069. Epub 2015 Aug 7.

引用本文的文献

1
Compatibilizing of cotton fabric with hydrophobic drug cover layer for anti-inflammatory performance with the implementation of ibuprofen.棉织物与疏水性药物覆盖层的兼容,以实现布洛芬的抗炎性能。
Sci Rep. 2024 Mar 27;14(1):7310. doi: 10.1038/s41598-024-57883-5.
2
Simvastatin/hydrogel-loaded 3D-printed titanium alloy scaffolds suppress osteosarcoma via TF/NOX2-associated ferroptosis while repairing bone defects.载有辛伐他汀/水凝胶的3D打印钛合金支架在修复骨缺损的同时,通过TF/NOX2相关的铁死亡抑制骨肉瘤。
Bioact Mater. 2023 Nov 17;33:223-241. doi: 10.1016/j.bioactmat.2023.11.001. eCollection 2024 Mar.

本文引用的文献

1
Drug loading of polymer implants by supercritical CO2 assisted impregnation: A review.聚合物植入物的超临界 CO2 辅助浸渍载药:综述。
J Control Release. 2015 Jul 10;209:248-59. doi: 10.1016/j.jconrel.2015.05.002. Epub 2015 May 5.
2
The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine.药物物理状态对热熔挤出法制备的固体分散体溶出度增强的影响:以奥氮平为例的研究
J Pharm Sci. 2014 Apr;103(4):1214-23. doi: 10.1002/jps.23894.
3
Polymers for drug delivery systems.
药物输送系统用聚合物。
Annu Rev Chem Biomol Eng. 2010;1:149-73. doi: 10.1146/annurev-chembioeng-073009-100847.
4
Injection Molding and its application to drug delivery.注塑成型及其在药物传递中的应用。
J Control Release. 2012 May 10;159(3):324-31. doi: 10.1016/j.jconrel.2012.01.001. Epub 2012 Jan 10.
5
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review.基于聚乳酸-共-羟基乙酸的药物释放系统的药物释放机制——综述。
Int J Pharm. 2011 Aug 30;415(1-2):34-52. doi: 10.1016/j.ijpharm.2011.05.049. Epub 2011 May 27.
6
Effects of drug solubility, state and loading on controlled release in bicomponent electrospun fibers.药物溶解度、状态和载药量对双组分电纺纤维中控制释放的影响。
Int J Pharm. 2010 Sep 15;397(1-2):50-8. doi: 10.1016/j.ijpharm.2010.06.045. Epub 2010 Jul 3.
7
Characterization and stability of solid dispersions based on PEG/polymer blends.基于 PEG/聚合物共混物的固体分散体的特性和稳定性。
Int J Pharm. 2010 May 10;390(2):165-73. doi: 10.1016/j.ijpharm.2010.01.039. Epub 2010 Feb 10.
8
Controlling burst and final drug release times from porous polylactide devices derived from co-continuous polymer blends.控制源自共连续聚合物共混物的多孔聚丙交酯装置的突发和最终药物释放时间。
Biomacromolecules. 2009 Aug 10;10(8):2053-66. doi: 10.1021/bm8013632.
9
Engineered polymers for advanced drug delivery.用于先进药物递送的工程聚合物
Eur J Pharm Biopharm. 2009 Mar;71(3):420-30. doi: 10.1016/j.ejpb.2008.09.021. Epub 2008 Oct 17.
10
Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride.盐酸普萘洛尔缓释双层片的设计与评价
Acta Pharm. 2007 Dec;57(4):479-89. doi: 10.2478/v10007-007-0038-0.